Studies related to the prostate indicated that serum CXCL5 level is the relevant marker for men with benign prostatic hyperplasia (BPH), bacterial prostatitis, or chronic prostatitis, and a circulating marker involved in the inflammatory response [3,4,5]. This evidence concerns the gene CXCL5 and benign prostatic hyperplasia.